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According to statistics otosclerosis is a disease 
effecting millions. The essence of the pathological 
process is in the reconstruction taking place in the 
labyrinthine capsule. Through the process the footplate 
of the stapes becomes fixed in the oval window and as a 
result of this conductive hearing loss occurs which is 
continually increasing and in its advanced stage percep­
tional disorder, the damage of the Corti-organ develops. 
Vestibular disorders may be present, too and the only 
symptom is perceptive hearing damage in the cochlear 
appearance of the disease.
The aetiology of otosclerosis is not exactly known 
yet. The results of the latest examinations suggest that 
the pathogenetic base for the disease is the imbalance 
in the different enzymatic processes.
Presently, according to examinations the 
7-isopropoxy-isoflavon, or by its manufacturing name 
Yambolap, /produced by Chinoin/ has a favourable effect 
on the mitochondrial metabolism at the subcellular level. 
The cell metabolism requires lower oxygen consumption 
due to Ipriflavon treatment and because of this reminer­
alization becomes more effective.
Based on the present knowledge of biology, biochem­
istry and pharmacology, it may be supposed that Ipriflavon 
has a favourable effect /beside its other effects/ on 
every osteopathy which is in some way connected with 
disorders of mineralization or remodelling.
We have tested the preparation in the treatment of 
otosclerosis at the Ear-, Nose- and Throat Clinic of 
Szeged University of Medical Sciences.
Case record and method
Examinations were carried out on 53 otosclerotic 
patients of both sexes who were otherwise found healthy.
Forty-three patients were treated by Yambolap 
with the dosage of 3x200 mg per day.
Stapedectomy was performed on the patients within 
3 months, as a general rule, following the treatment.
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We have examined the stapes of 20 patients histolog­
ically.
Atomic absorption tests were done on auditory ossi­
cles of 23 patients for C a - , Zn-, and Cu-contents. For 
the purpose of comparison we determined components of the 
cortical bone-samples for the same patient.
Ten patients received placebo.
All patients had thorough otorhinolaryngological 
and audiological examinations, complete blood-counts, 
and urinanalysis.
These examinations were repeated after a period of 
1 week, 1 month, 3 months and 6 months following the begin­
ning of treatment.
Results were compared to findings of untreated oto- 
sclerotic patients who were given placebo.
Results - Discuss ion
We found Schwartze-phenomenon in 11 cases which dis­
appeared in 6 cases after 3 months of treatment by Yambolap,
At the evaluation of the subjective complaints the 
most remarkable observation was the effectiveness of 
Yambolap upon tinnitus.
From the 43 patients treated with Yambolap 40 re­
ported on a certain degree of tinnitus. After 3 months 
of treatment by Yambolap tinnitus in 12 patients /30%/ dis­
appeared, tinnitus in 16 patients /40%/ decreased, com­
plaints of 12 patients /30%/ were unchanged.
From the 1C patients taking placebo, the originally 
slight tinnitus in 1 patient disappeared, tinnitus in 1 
patient decreased, complaints of 8 patients were unchanged.
Changes in clear-tone hearing threshold
After 3 months of the treatment the hearing of 28 
patients /65%/ did not change or improvement was shown 
only within the 5 dB limit of error, 12 patients /28%/ 
had a 10 dB or more improvement in hearing. The hearing 
of 3 patients / 7% /  deteriorated under the course of 
treatment.
The hearing of patients belonging to the control 
group had not improved, in fact, the hearing of 3 patients 
became worse under the time of examinations.
Operative findings
Operations were performed more easily on treated 
than on untreated patients. Bleeding has remained under 
the usual level during operations. In most of the treated 
cases the stapes could be removed intact while in cases 
of untreated patients the superstructure was generally 
broken off and the footplate of the stapes could be lifted 
out only in fragments.
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Histological examinations
Compared to untreated cases it seemed that the number 
of osteoclasts decreased in the otosclerotic focuses. The 
mesenchymal cells became osteoblasts, then osteocytes. 
Calcification occurred at the perivascular regions and at 
the perimeter /edge/ of the focuses. Therefore, Ipriflavon 
/Yambolap/ promotes the deposition of lime salts in the 
fibrous interstitial tissue of the focuses. Probably, the 
healing of the otosclerotic focuses was induced by a primary 
metaplastic osteogenesis,also preventing the progress of 
the disease.
Atomic absorption tests
The Ca-content of the cortical bone has not changed 
by the treatment.
The Ca-content of the untreated otosclerotic stapes 
was usually lower than in the cortical bones serving as 
standard control. The Ca-content of the auditory ossicles 
became definitely higher, often by more than 50 per cent, 
as a result of Ipriflavon treatment.
The Zn-content of the stapes was also higher than in 
the cortical bone, and approximately a 5 per cent, and a 
16 per cent increase could be detected in the cortical 
bone and auditory ossicles, respectively, in the cases of 
treated patients.
The Cu-content of the stapes was also higher than 
the Cu-content measured in the cortical bone. For the 
effect of treatment Cu-content increased by 32 per cent 
while increase in the cortical bone was only 7 per cent.
We may conclude that there is a relation between the 
changes of Ca-, Zn- and Cu-contents in cases treated by 
Yambolap. The process taking place may be explained so 
that for the effect of Yambolap the activity of enzymes 
necessary to Ca-incorporation increases /increase in 
Cu- and Zn-contents/ which is resulting in a rise of the 
Ca-level observed by us.
Summary
We have studied the effect of Ipriflavon /Yambolap/ 
in 43 patients who had suffered from otosclerosis.
It is evident that tinnitus, one of the most torment­
ing symptoms of the disease, disappears or becomes moder­
ated in the majority of cases. Also hearing impairment 
may be arrested at an early stage, in fact, hearing may 
even improve. Considering the improvement of clinical 
symptoms /e.g. the disappearing of Schwartze-phenomenon, 
and tinnitus, improvement of hearing/, less bleeding at 
the operations, the easy removal of the footplate of the 
stapes, the results of histologic examinations and atomic 
absorption tests, we may come to the conclusion that the 
activity of the otosclerotic focuses decreases, and the 
process of remineralization increases in the bone.
We have not found any harmful side effect of the 
drug beside the employed dosages.
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